AGER and cystic fibrosis: Indeed, treatment with soluble RAGE, an inhibitor decoy receptor, was able to prevent fungal growth and reduce inflammatory pathology [3], thus highlighting the importance of RAGE in driving inflammation in CF by coupling host- and microbial-derived stimuli.